Inventiva SA(IVA.US)

Last Updated 19:00:00 ET
longbridge loading

Assessing Inventiva (ENXTPA:IVA) Valuation After Recent Share Price Volatility

Simplywall·
US
IVA
-0.78%
Simplywall·
US
IVA
-0.78%

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026

Tip Ranks·
US
IVA
-0.78%
US
PHAR
0.00%
US
ATAI
+1.10%
Tip Ranks·
US
IVA
-0.78%
US
PHAR
0.00%
US
ATAI
+1.10%

A Look At Inventiva (ENXTPA:IVA) Valuation As New Leadership Team Prepares For Key Phase 3 Readout

Simplywall·
US
IVA
-0.78%
US
PBE
0.00%
US
FBT
-0.72%
Simplywall·
US
IVA
-0.78%
US
PBE
0.00%
US
FBT
-0.72%

Inventiva (NASDAQ:IVA) Sees Unusually-High Trading Volume - Still a Buy?

Market Beat·
US
IVA
-0.78%
Market Beat·
US
IVA
-0.78%

Inventiva SA Bets Big on Pivotal MASH Trial

Tip Ranks·
US
IVA
-0.78%
US
FBT
-0.72%
US
ARKG
-1.30%
Tip Ranks·
US
IVA
-0.78%
US
FBT
-0.72%
US
ARKG
-1.30%

Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

benzinga_article·
US
SVC
-2.54%
US
ARKG
-1.30%
US
XBI
-0.88%
benzinga_article·
US
SVC
-2.54%
US
ARKG
-1.30%
US
XBI
-0.88%

Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update

Market Beat·
US
PBE
0.00%
US
FBT
-0.72%
US
LABU
-2.66%
Market Beat·
US
PBE
0.00%
US
FBT
-0.72%
US
LABU
-2.66%

LifeSci Capital Sticks to Their Buy Rating for Inventiva (IVA)

Tip Ranks·
US
IXJ
-0.69%
US
FBT
-0.72%
US
SBIO
+0.04%
Tip Ranks·
US
IXJ
-0.69%
US
FBT
-0.72%
US
SBIO
+0.04%

Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints

Tip Ranks·
US
IVA
-0.78%
US
LABU
-2.66%
US
XBI
-0.88%
Tip Ranks·
US
IVA
-0.78%
US
LABU
-2.66%
US
XBI
-0.88%
© 2026 Longbridge｜Disclaimer